JO3159B1 - عملية للتصنيع الانزيمي لـ (7 s)-1-(3.4-دايميثوكسيبايسكلو(4.2.0) اوكتا-1.3.5-ترين-7-ايل) N-ميثيل ميثانامين وتطبيق الايفاربرادين واملاحه في التصنيع - Google Patents

عملية للتصنيع الانزيمي لـ (7 s)-1-(3.4-دايميثوكسيبايسكلو(4.2.0) اوكتا-1.3.5-ترين-7-ايل) N-ميثيل ميثانامين وتطبيق الايفاربرادين واملاحه في التصنيع

Info

Publication number
JO3159B1
JO3159B1 JOP/2013/0191A JOP20130191A JO3159B1 JO 3159 B1 JO3159 B1 JO 3159B1 JO P20130191 A JOP20130191 A JO P20130191A JO 3159 B1 JO3159 B1 JO 3159B1
Authority
JO
Jordan
Prior art keywords
synthesis
ivabradine
trien
octa
application
Prior art date
Application number
JOP/2013/0191A
Other languages
English (en)
Inventor
Gonzalez Sabin Javier
Pedragosa Moreau Sandrine
Moris Varas Francisco
Lefoulon Francois
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of JO3159B1 publication Critical patent/JO3159B1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/04—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/006—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
    • C12P41/008—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures by reactions involving carbamates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003—Triacylglycerol lipase (3.1.1.3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

عملية للمركب الأنزيمي من الصيغة (1)، (7س) – 1 – (3،4 – داي ميثوكسي ثنائي الحلقة (4،2،0) أوكتا – 5،3،1 –تريين – 7 – يل) ن-ميثيل ميثانامين. وتطبيق على مركب الإفابرادين والأملاح الإضافية الخاصة بها مع الحمض المقبول صيدليا.
JOP/2013/0191A 2012-07-17 2013-06-23 عملية للتصنيع الانزيمي لـ (7 s)-1-(3.4-دايميثوكسيبايسكلو(4.2.0) اوكتا-1.3.5-ترين-7-ايل) N-ميثيل ميثانامين وتطبيق الايفاربرادين واملاحه في التصنيع JO3159B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1256913A FR2993561B1 (fr) 2012-07-17 2012-07-17 Procede de synthese enzymatique de la (7s)-1-(3,4-dimethoxy bicyclo[4.2.0]octa-1,3,5-triene 7-yl) n-methyl methanamine, et application a la synthese de l'ivabradine et de ses sels

Publications (1)

Publication Number Publication Date
JO3159B1 true JO3159B1 (ar) 2017-09-20

Family

ID=46826832

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2013/0191A JO3159B1 (ar) 2012-07-17 2013-06-23 عملية للتصنيع الانزيمي لـ (7 s)-1-(3.4-دايميثوكسيبايسكلو(4.2.0) اوكتا-1.3.5-ترين-7-ايل) N-ميثيل ميثانامين وتطبيق الايفاربرادين واملاحه في التصنيع

Country Status (33)

Country Link
US (1) US9045788B2 (ar)
EP (1) EP2687506B1 (ar)
JP (1) JP5822880B2 (ar)
KR (1) KR101495614B1 (ar)
CN (1) CN103540625B (ar)
AR (1) AR091765A1 (ar)
AU (1) AU2013206562B2 (ar)
BR (1) BR102013017550A2 (ar)
CA (1) CA2820192C (ar)
CY (1) CY1116500T1 (ar)
DK (1) DK2687506T3 (ar)
EA (1) EA024637B1 (ar)
ES (1) ES2547897T3 (ar)
FR (1) FR2993561B1 (ar)
GE (1) GEP20156422B (ar)
HR (1) HRP20150906T1 (ar)
HU (1) HUE025113T2 (ar)
JO (1) JO3159B1 (ar)
MA (1) MA34880B1 (ar)
MD (1) MD4375C1 (ar)
MX (1) MX341588B (ar)
MY (1) MY177115A (ar)
NZ (1) NZ612592A (ar)
PL (1) PL2687506T3 (ar)
PT (1) PT2687506E (ar)
RS (1) RS54082B1 (ar)
SA (1) SA113340722B1 (ar)
SG (1) SG196717A1 (ar)
SI (1) SI2687506T1 (ar)
TW (1) TWI485250B (ar)
UA (1) UA113052C2 (ar)
UY (1) UY34900A (ar)
WO (1) WO2014013179A1 (ar)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6616934B2 (ja) * 2014-05-22 2019-12-04 株式会社 資生堂 レナリドミドの光学分割方法
EP3101010A1 (en) 2015-06-03 2016-12-07 Urquima S.A. New method for the preparation of highly pure ivabradine base and salts thereof
CN110656134B (zh) * 2018-06-29 2023-03-28 广东东阳光药业有限公司 一种单酯的制备方法
CN110483312A (zh) * 2019-08-27 2019-11-22 北京阳光诺和药物研究有限公司 一种高纯度盐酸伊伐布雷定及其中间体的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
US5981267A (en) * 1996-01-24 1999-11-09 The Scripps Research Institute Enantioselection of amines using homocarbonates with hydrolase
CN100412062C (zh) * 2001-09-12 2008-08-20 阿诺麦德股份有限公司 对映体纯的氨基取代稠合双环的合成
KR100510379B1 (ko) * 2003-07-31 2005-08-25 동부아남반도체 주식회사 트렌치 소자 분리 형성 방법
FR2868775B1 (fr) * 2004-04-13 2008-04-11 Servier Lab Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2870537A1 (fr) * 2004-05-19 2005-11-25 Servier Lab Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2935381B1 (fr) * 2008-08-29 2010-12-17 Servier Lab Nouveau procede de resolution des enantiomerees du (3,4-dimethoxy-bicyclo°4.2.0!octa-1,3,5-trien-7-yl)nitrile et application a la synthese de l'ivabradine
EP2367782B1 (en) * 2008-12-22 2013-02-13 KRKA, D.D., Novo Mesto Process for preparation of ivabradine
HUP1000245A2 (en) * 2010-05-07 2011-11-28 Richter Gedeon Nyrt Industrial process for the production ivabradin salts
EP2495237A1 (en) * 2011-03-04 2012-09-05 Alembic Pharmaceuticals Limited An improved process for the preparation of highly pure ivabradine hydrochloride

Also Published As

Publication number Publication date
MX341588B (es) 2016-08-26
EA201300719A3 (ru) 2014-04-30
GEP20156422B (en) 2016-01-11
US9045788B2 (en) 2015-06-02
MX2013008022A (es) 2014-01-21
MY177115A (en) 2020-09-07
TWI485250B (zh) 2015-05-21
HRP20150906T1 (hr) 2015-09-25
KR101495614B1 (ko) 2015-02-25
SA113340722B1 (ar) 2015-07-23
CA2820192C (fr) 2016-03-22
JP2014018204A (ja) 2014-02-03
EP2687506A1 (fr) 2014-01-22
EA201300719A2 (ru) 2014-02-28
EA024637B1 (ru) 2016-10-31
CN103540625B (zh) 2016-08-17
MD4375C1 (ro) 2016-05-31
BR102013017550A2 (pt) 2015-06-30
SG196717A1 (en) 2014-02-13
KR20140010900A (ko) 2014-01-27
UY34900A (es) 2014-02-28
PL2687506T3 (pl) 2015-10-30
US20140024088A1 (en) 2014-01-23
AU2013206562A1 (en) 2014-02-06
TW201406960A (zh) 2014-02-16
WO2014013179A1 (fr) 2014-01-23
CY1116500T1 (el) 2017-03-15
AU2013206562B2 (en) 2017-02-02
CN103540625A (zh) 2014-01-29
RS54082B1 (sr) 2015-10-30
ES2547897T3 (es) 2015-10-09
PT2687506E (pt) 2015-08-11
FR2993561A1 (fr) 2014-01-24
MD20130045A2 (en) 2014-01-31
NZ612592A (en) 2014-05-30
JP5822880B2 (ja) 2015-11-25
AR091765A1 (es) 2015-02-25
MD4375B1 (ro) 2015-10-31
EP2687506B1 (fr) 2015-06-24
FR2993561B1 (fr) 2014-10-31
MA34880B1 (fr) 2014-02-01
SI2687506T1 (sl) 2015-11-30
CA2820192A1 (fr) 2014-01-17
UA113052C2 (xx) 2016-12-12
DK2687506T3 (en) 2015-09-28
HUE025113T2 (en) 2016-02-29

Similar Documents

Publication Publication Date Title
JO2807B1 (ar) عملية جديدة لتركيب ايفابرادين وأملاح إضافة له مع حامض مقبول صيدلانيا.
MY146245A (en) New process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
MY156630A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
JO2781B1 (ar) عملية جديدة لتركيب ايفابرادين وأملاح إضافة له مع حامض مقبول صيدلانيا.
MY169295A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
SA113340722B1 (ar) عملية للتخليق الإنزيمي للمركب (s7) - 1 - (3، 4 - داي ميثوكسي باي سيكلو [4-2-0] أوكتا - 1، 3، 5 - ترايين - 7 - يل) n - ميثيل ميثان أمين، واستخدامه في تخليق إيڤابرادين وأملاحه
JO2930B1 (ar) عملية جديدة لتركيب إيفابرادين وأملاح إضافة منها مع حامض مقبول دوائياً
JO2782B1 (ar) عملية جديدة لتركيب ايفابرادين وأملاح إضافة له مع حامض مقبول صيدلانيا.
JO2854B1 (ar) طريقة جديدة لتركيب الأنفابرادين وأملاحه المضافة مع حمض يكون مقبولا صيدلانيا.
JO3054B1 (ar) طريقة تركيب إنزيمي لـ (7 اس) – 3، 4 – ثنائي ميثوكسي سيكلو [4.2.0] أوكتا – 1.3.5 – تريين – 7 – حمض كربوكسيلي أو إستر منه وتطبيقه في تركيب الايفابرادين وأملاح منه
MY170662A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
SG10201402034PA (en) Process for the synthesis of 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carbonitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
MY159691A (en) New process for the synthesis of 3-(2-bromo-4,5-dimethoxyphenyl)propanenitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
MX347536B (es) Procedimiento de sintesis enzimatica del acido (7s)-3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-carboxilico y aplicacion en la sintesis de ivabradina y de sus sales.
SA113340412B1 (ar) عملية جديدة لتصنيع إيڤابرادين وأملاح إضافة منه مع حمض مقبول صيدلانياً
JO3083B1 (ar) عملية جديدة لتخليق إيفابرادين وأملاحه المضافة مع حمض مقبول صيدلانيا
SA113340924B1 (ar) عملية جديدة لتخليق 3- (2- برومو- 4،5 - داي ميثوكسي فينيل)بروبان نيتريل، وتطبيقها في تخليق إيڤابرادين وأملاح الإضافة منه مع حمض مقبول صيدلانياً
SG165255A1 (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid